<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: (Anxiety Disorder News) EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3 Clinical Trial at 47th Annual NCDEU Meeting (Business Wire via Yahoo! Finance)</title>
	<atom:link href="http://www.treatanxietydisorder.com/PanicAttack/anxiety-disorder-news-epix-pharmaceuticals-presents-findings-from-prx-00023-phase-3-clinical-trial-at-47th-annual-ncdeu-meeting-business-wire-via-yahoo-finance/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.treatanxietydisorder.com/PanicAttack/anxiety-disorder-news-epix-pharmaceuticals-presents-findings-from-prx-00023-phase-3-clinical-trial-at-47th-annual-ncdeu-meeting-business-wire-via-yahoo-finance/</link>
	<description>Premium Resource For Treating Anxiety Disorder</description>
	<lastBuildDate></lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	</channel>
</rss>
